SciELO - Scientific Electronic Library Online

 
vol.19 issue1Adherence to condom use: the real behavior in the Northeast of BrazilDynamics of the malaria epidemic in Colombia: temporal probabilistic prediction author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de Salud Pública

Print version ISSN 0124-0064

Rev. salud pública vol.19 no.1 Bogotá Jan./Feb. 2017

http://dx.doi.org/10.15446/rsap.v19n1.55933 

Artículos/Investigación

Proportion of fever attributable to malaria in Colombia: Potential indicators for monitoring progress towards malaria elimination

Proporción de fiebre atribuible a malaria en Colombia: Indicadores potenciales para el seguimiento hacia la eliminación

María V. Valero-Bernal1  , Marcel Tanner2  , Sergio Muñoz-Navarro3  , José F. Valero-Bernal4 

1VB: Ph. D. Epidemiology and Dr. Public Health. Faculty of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia. mvvalerober@unal.edu.co

2MT: MD. Ph. D. Epidemiology. Dhc. Director-Emeritus, Swiss Tropical and Public Health Institute, University of Basel. President, Academia of Sciences. Basel, Switzerland. Marcel.tanner@unibas.ch

3SM: Biostatistician. Ph. D. Biostatistics. Director, School of Public Health. Faculty of Medicine, Universidad de La Frontera. Temuco, Chile. sergio.munoz.n@ufrontera.cl

4JV: MD. Anesthesiologist. Surgery Department Anesthesiology Unit, Faculty of Medicine, Universidad Nacional de Colombia. Bogotá, Colombia. jfvalerob@unal.edu.co

ABSTRACT

Objective

Identify and characterize indicators to assess progress in terms of control and monitoring of malaria in endemic areas of Colombia and compare malaria elimination findings with those of countries in the same region.

Methods

Cross-sectional surveys were carried out in 2011 and 2014 in malaria endemic areas in Colombia, Pacific and Caribbean regions. A socio-demographic and a clinical questionnaire were applied to each participant; likewise, written and informed consents were obtained. Capillary blood samples were taken and examined through microscopic tests and rapid diagnostic test. A narrative systematic review was conducted to correlate malaria elimination in Colombia and in countries of the Amazon Region.

Results

The sample consisted of 548 participants from the departments of Córdoba and Nariño, Colombia. The proportion of positive malaria cases was 3 % (17/548), in which the prevalence of malaria mixed infections was 47 % (8/17). Regarding fever, temperature over 38.0o C, its prevalence was 2.7 % (15/548). Only two febrile patients tested positive for the disease. Prevalence of asymptomatic malaria cases among all positive cases was 88 %.

Conclusion

Asymptomatic malaria cases, mixed infections and self-medication are the challenges that malaria control and elimination programs face. It is important to note that studies on subclinical malaria in the region are scarce. Endemic areas with dense populations and experiencing an increase in immigration levels are more vulnerable to malaria reemergence. Imported malaria cases impact the basic reproduction rate (Ro). Funding resources availability has impact on the sustainability of public health actions and the elimination of malaria in South America.

Key words: Malaria; febrile; disease eradication; public health; surveillance; South America (source: MeHS, NLM)

RESUMEN

Objetivo

Identificar y caracterizar indicadores de evaluación del progreso en el control de la malaria en regiones endémicas de Colombia y contrastar los hallazgos de eliminación con países de la misma región.

Métodos

Se realizaron cortes transversal en 2011 y 2014, en regiones endémicas para malaria de la Costa Pacífica y del Caribe de Colombia. Se obtuvo consentimiento informado y se aplicó una encuesta socio-demográfica y clínica a cada voluntario. La punción capilar se utilizó para examen microscópico y pruebas de diagnóstico rápido. La revisión narrativa y sistemática permitió comparar el estado de eliminación de malaria en Colombia y los países de la Amazonía.

Resultados

Un total de 548 voluntarios fueron estudiados en Córdoba y Nariño. La proporción de casos positivos de malaria fue 3 % (17/548). Las infecciones mixtas de malaria se presentaron en un 47 % (8/17). La prevalencia de fiebre, temperatura mayor o igual a 38oC, fue 2.7 % (15/548). Dos pacientes febriles fueron positivos para malaria. La prevalencia de casos asintomáticos se presentó en 88 %.

Conclusión

Los casos de malaria asintomática, infecciones mixtas y la automedicación constituyen un reto para los programas de control y eliminación. Estudios sobre malaria subclínica y eliminación son limitados en la región. Regiones endémicas con alta densidad poblacional y aumento en los niveles de migración incrementan la vulnerabilidad. Los casos importados afectan la reducción de la tasa reproductiva básica (Ro) por debajo de 1. El recurso financiero insuficiente afecta la sostenibilidad de las acciones de salud pública y la eliminación de malaria en las Américas.

Palabras-clave: Malaria; febril; erradicación de la enfermedad; vigilancia en salud pública; América del Sur (fuente: DeCS, BIREME)

Malaria persists as the major global public health problems. Traditionally, solutions have centered on biological approach, such as treating the parasitic infection and vector control, without taking socio-economic and environmental factors into account. This paradigm has proved to be insufficient for advancing control strategies and progressive elimination. The main challenge has been early diagnose and prompt treatment. Unfortunately, failure treatment in clinical cases and adhesion to radical treatment affect the process, outcome and impact indicators of control programs.

In Latin America, the first chloroquine resistance case was registered in Tumaco, Colombia in1960. 1,2. One possible factor contributing to the spread of drug resistance in the region was the frequency of presumptive treatment for all febrile cases without follow up, and not radical treatment for all positive confirmed cases 3,4, by first Eradication Era . More recently the failures treatment are associate to poor treatment adherence and self-medication with natural herbs as a consequence of limited access to health malaria services 5.

New global malaria elimination efforts guided by the WHO’s Global Technical Strategy (WHO, 2015) and Roll Back Malaria Initiatives_RBI’s action and investment framework 6 (RBM 2015) point to several key elements, including better knowledge of malaria epidemiology patterns at different endemic levels, which can be used to estimate the potential impact of novel malaria reduction strategies 7-9.Integrated strategies tailored to specific endemic settings, such as combined therapies, intermittent preventive treatments (IPT),and rapid diagnostic testing 10, have been shown to reduce case-fatality rates associated with P. falciparum.11-13. However, this is not the case for P. vivax, owing to its dormant forms in the liver and the possibility of relapse, and to the reservoir of asymptomatic cases. In addition, the high rates of mixed malaria infections in countries like Colombia limit the possibilities for elimination. Mixed malaria infections are widely correlated with inadequate treatment and self-medication, with limited quality control strategies for blood samples, and with considerable difficulties accessing health services, thereby preventing patient control during the pathogenic period 14,15.

In Latin America, global pre-elimination and elimination strategies have led to the introduction of various integral strategies at three levels: parasite, host, and vector 16,17. In this context, (i) few studies have considered the impact of asymptomatic cases on the basic case reproduction rate (Ro), and (ii) there is still a need to define and quantify the proportion of fever attributable to malaria and its implications for elimination in different endemic settings 18,23. The purpose of this study was to explore the association between malaria infection and fever as a potential way of tracking progress towards malaria control and elimination in low endemic areas and to compare the changes in species’ transmission patterns. The level and distribution of symptomatic and asymptomatic cases was assessed and findings correlated to potential transmission risks as a basis from which to develop improved models of control and elimination in Colombia.

METHODS

The study was conducted in two endemic areas in Colombia: Nariño and Cordoba, Pacific and Caribbean coast. Blood samples were obtained from urban and rural areas in San Andres de Tumaco (1°48′24″N 78°45′53″W) and the Olaya Herrera (2°20′49″N 78°19′32″W), Nariño. This region is endemic for falciparum malaria around 80% and Afro-Colombian population. In Cordoba, the study concentrates on Puerto Libertador (7°53′17″N 75°40′18″W) and the Montelibano (7°58′16″N 75°25′05″W), both endemic areas for vivax malaria and high prevalence of transmission of other vector borne diseases. Cordoba department registers 9% of total positive cases according to the National Malaria Surveillance System of Colombia24.

A complementary qualitative systematic review was conducted, using Embase, Pubmed, and Bireme databases, period 2000-2015. Search terms included asymptomatic, fever attributable to malaria, elimination, eradication and control of malaria in South America and Colombia. Search equations were elaborated to obtain more precise information related to malaria elimination and control indicators. The references were captured in Endnote X7. Duplicate records were eliminated. Each abstract meeting the inclusion criteria were selected for analyses of frequency and association measures.

Cross sectional surveys conducted in 2011 and 2014 were compared to 1995 historical cross sectional survey data for San Francisco village 25. This dataset was presented by the World Malaria Atlas (26), and it was classified as area of high endemic risk (API > 100 per 1000 in habitants); unfortunately, this village, disappeared due the long period of political unrest, making no feasible additional studies 5,27.

Local malaria control program verified village with current evidence of autochthones cases. Each village was invited to participate and after writing consent the study was conducted. Sampling by convenience was done, and participants located in each information post with help of local leaders. Protocols of security for humanitarian mission were activated according to particular conditions. From each volunteer a capillary blood sample was taken one for a thick blood smear, and for Rapid Diagnose Test, RDT, manufactured by Standard Diagnostic Inc. Asymptomatic cases were defined as any person without symptomatology compatible to malaria, but showing a positive RDT. Fever was defined as any patient with more than or equal to 38,0 Celsius degrees according to WHO Guidelines. Treatment of malaria episodes: individuals with malaria infections were treated according to malaria guidelines of the National Control program in Colombia 28,29. In Latin America a case of malaria is defined as all patients with or without symptomatology and positive presence of parasites. The descriptive statistics and association were estimated using Stata 13. The level of significance was at 5 %.

Ethical considerations

The study was undertaken according to the principles of the Helsinki declaration and Resolution 8430 of the Ministry of Health of Colombia, 1993.The study was cleared by the Ethical Committee, of the Faculty of Medicine at the Universidad Nacional de Colombia. Informed consent was obtained from all study participants. For volunteers less than 18 years old, the parents or legal guardian authorized participation (Articles 23 and 24 of Resolution 8430). According to national norms, the investigation was classified of minimal risk (Article 11).

RESULTS

A total of 528 subjects were sampled. Table 1 shows the prevalence of positive cases, defined as infected with or without symptomatology.

Table 1 Socio-demographic characteristics of the sampled population 

The villages selected for the study experienced intense political unrest and had a high proportion of displaced populations, mainly in Cordoba, on rural areas. According to CODHES, Colombia recorded five million displaced people by 201330. From field observations the self medication was confirmed. The consumption of herbal infusions to reduce fever is very common in all areas. In Tumaco, people prepare infusions of Cinchona Bark while all drug stores close to the temporary field station sold the tonic, “Arquin”, each 100 ml containing 0.566g of chloroquine. Given the limited diagnostic services in the area and the cost of transport to a well-equipped health center, most people with fever or malaria-compatible symptomatology take these available products.

Table 2 shows the demographic and clinical characterization of the detected malaria cases. Prevalence did not differ by sex or occupation. The findings suggest that P.vivax and mixed infections are a key public health problem in those areas. The age distribution of cases kept the historical epidemiology for these areas. The ages affected by the infection and disease are grouped between 15-45 yrs. However, 70 % of infected subjects were asymptomatic and the proportion of fever attributable to malaria was 42 %.

Table 2 Malaria cases distribution by municipality and species 

San Francisco Village study: Historical comparison, 1995

This Village was located on Tumaco rural area, over the Rosario River. A total of 1,685 thick blood smears were taken. 41(2.4 %) patients reported fever, i.e. temperature > 38o C, and 151 (8.9 %) tested positive for parasites microscopically (6.2 % P. falciparum and 2.3 % P. vivax). The total proportion of positive cases in febrile episodes was 86 % (19/22) and 8.7 % (132/1,512) in afebrile subjects. The crude odds ratio of the association fever/parasitaemia was 9.9 (95 % confidence intervals, CI, 5.2 %-18.7 %, p-value <0.001). After adjusting for age and sex, the OR was 10.8 (95 % CI 5.6-20.8, p-value <0.001).The crude proportion of fever attributable to malaria (PAF) was a 41.7%(95 % CI 31.3%-55.3 %) and 42 % (95 % CI, 38.1-44.1, p-value<0.001) after adjusting for age and sex 31.

On this particular survey fever due by malaria increased with the level of parasite density and, consequently, the frequency of fever associate to malaria decreases with age 31. After adjusting for age and sex, the odds of fever was 12.1 times higher among individuals exposed to Plasmodium vivax malaria parasites compared to those who were not exposed. Although, a high association was also observed among those exposed to Plasmodium falciparum malaria, OR=11.4, it was slightly lower. However, the proportion of fever attributable to Plasmodium falciparum was 33.2 % higher than the fraction of fever attributable to Plasmodium vivax, where the proportion of fever attributable to malaria was =16.4 %31.

During the last 20 years, there is a slightly reduction of asymptomatic and the PAF. The population of San Francisco was in the middle of all actors in the armed conflict and additional surveys were not possible; however the other regions sampled keep similar epidemiological conditions and same socio-economic factors which affect Tumaco and the Pacific coast endemic areas.

Table 3 presents most relevant aspects of the malaria control program of the eight countries on the same Amazon Region where Colombia also share similar eco-epidemiological conditions. These findings suggest limited actions of surveillance and budget constraint. The case detection in some areas combine intensified active case detection. The activities are responsibility of the public sector, the review do not find the private health sector participation in most of the countries. The surveillance system in Colombia and other countries present data from years before 2013, there is not available data for more recent years. The surveillance system is not opportune and sensible in case detection. It is widely suggest levels of under report around 35 % 15.

Table 3 Results of the qualitative review of malaria pre-elimination and elimination programs: Case study of countries with territories in the Amazon Region 32,42  

DISCUSSION

The findings show that P. vivax malaria is still endemic in Cordoba, while P. falciparum continues to be the main problem in Tumaco. The frequency and distribution of P. vivax and mixed infections indicate a weak effectiveness of malaria treatment in terms of prescriptions, delayed access and limited supervision by health system. As other authors refer, Plasmodium vivax represents de 80 % of clinical malaria cases in Latin America and the Caribbean Island, meanwhile Plasmodium falciparum remains as a main cause of mortality 6 deaths per 100 000 inhabitants 32,43

Policies and strategies for moving from malaria control to elimination require adequate planning to account for transmission levels and for the structure of health and social systems. Identification of asymptomatic and imported cases is key elements for malaria control planning. Assessing surveillance capacity and selecting relevant indicators for surveillance and monitoring are key preparatory issues that help to understand how the health and social systems function in a given place. Endemic countries must work in redefine and unified clinical malarial guidelines and protocols for malaria transfusion at both rural and urban areas. It is important establish algorithms and diagnose criteria between semi immune population and immune populations from non-endemic and endemic regions. The impact and cost of malaria treatments due to inadequate management and implementation could be reduced by additional research to identify state of drug resistance and permanent sentinel surveillance systems44,45.

The monitoring and evaluation of strategies of malaria elimination must be permanent. Definition of what would contribute to forecast outbreaks and epidemics. The early detection of clinical failures in treatments will reduce the cost of changing treatments.

Latin America, has recorded contrasting evidence about the association of malaria and fever as a main symptom17,23. In similar regions, authors present contradictory results about the prevalence of asymptomatic infections, ranging from 4.2 % to 96 % 18,19,21,22,46. In Colombia, two studies conducted in Chocó and Cordoba showed similar trends to those mentioned above. The study in Quibdo, highly endemic for P. falciparum, showed the absence of asymptomatic cases among schoolchildren47. Meanwhile in Tierralta, an area endemic for P.vivax, the study found 14.6 %of cases were asymptomatic 23. These findings coincide with our results, showing exposure differences by sex and age, as well as the different symptomatic behavior patterns of the two species P. falciparum and P. vivax. Therefore, the differences in age and sex between the febrile and afebrile cases cannot be just a chance finding and merits further exploration.

These results are consistent with previous findings from other authors on the same region 11,48,49. However, it must be noted that the proportion of fever attributable to malaria appears stable at around 39-42 %. The degree of self-medication in some areas remains an important challenge to national efforts towards developing effective surveillance systems (SIVIGILA and INVIMA)

The findings of this study have implications on malaria elimination program. Currently, a malaria case is defined as any case that tests positive for parasites by thick blood smear and/or RDT. Presently, clinical cases are detected by passive case detection (PCD). Active case detection has been reduced due to costs, such as those associated with transport to endemic areas. In Colombia, the priorities are: (i) to develop strategies for surveillance-response systems adapted to a given endemic area and (ii) to adapt new strategies for primary and secondary preventive actions which consider inter sectorial partnerships.

The systematic narrative study and fieldwork show how the evidence between countries varies. There is not enough temporal and spatial information to indicate the real status of malaria elimination and pre elimination efforts in Latin America, mainly in the Amazon region. Any attempts to discuss progress towards malaria elimination will first have to elucidate and define parameters for statistically significant comparisons. Mathematical models offer a way to predict the value of progress indicators, while related informatics systems can help to evaluate the impact of elimination and control efforts considering variables of place, time and person. Tracking these epidemiological markers from infection to illness, plus setting a new threshold of fever, must be evaluated in both the short- and long-term to really have an impact on the malaria elimination strategy and redefine new programs. Finally, sentinel surveillance systems to measure and establish the state of native cases versus imported is also required between countries. The weekly report must be mandatory to forecast epidemics and prevent early presence of imported cases and avoid the malaria reintroduction in areas with Reproductive Rate close to Zero.

Acknowledgment

This research was supported by the Swiss Tropical and Public Health Institute and the Universidad Nacional de Colombia, Faculty of Medicine. We are in debt to Professor Andy Hall of LSHTM for his preliminary comments. We particularly thank the study participants from these endemic regions for their understanding and contribution. Their willingness to participate without any remuneration and in spite of their precarious living conditions is greatly appreciated. We are in debt to Prof. Fabio Zicker, FIOCRUZ, who read this document and made some useful critiques and commentaries. Thanks to Ms. Amena Briet because her dedication and effort with the English edition.

References

1. WHO. Eighth Report of the Expert Committee on Malaria. Tech Rept Ser. 1961;205:7. [ Links ]

2. OMS/OPS. Evaluación de la eficacia terapéutica de los medicamentos para el tratamiento del paludismo por Plasmodium falciparum sin complicaciones en las Américas. Washington D.C: Panamerican Health Organization, 1998 [ Links ]

3. Gusmão R. Overview of malaria control in the Americas. Parassitologia. 1999;41(1-3):355-60. [ Links ]

4. PAHO. Resolution CSP27.R11: Malaria in the Americas. 27th Pan American Sanitary Conference. Washington, DC: Panamerican Health Organization, 2007 28 March 2008. En csp27.r11-e.pdf, acceso octubre 4 de 2016. [ Links ]

5. Valero-Bernal MV. Malaria in Colombia: retrospective glance during the past 40 years. Revista de Salud Pública. 2006;8:141-9. [ Links ]

6. Osterholt DM, Rowe AK, Hamel MJ, Flanders WD, Mkandala C, Marum LH, et al. Predictors of treatment error for children with uncomplicated malaria seen as outpatients in Blantyre district, Malawi. Trop Med Int Health. 2006;11(8):1147-56. [ Links ]

7. Tanner M, Hommel M. Towards malaria elimination - a new thematic series. Malaria Journal. 2010;9(1):24. [ Links ]

8. WHO. Wolrd Malaria Report 2009. Geneva: WHO, 2009. [ Links ]

9. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, Hay SI, et al. The Limits and Intensity of Plasmodium falciparumTransmission: Implications for Malaria Control and Elimination Worldwide. PLoS Med. 2008;5(2):e38. [ Links ]

10. Ehrhardt S, Mockenhaupt FP, Eggelte TA, Agana-Nsiire P, Stollberg K, Anemana SD, et al. Chloroquine blood concentrations and molecular markers of chloroquine-resistant Plasmodium falciparum in febrile children in northern Ghana. Trans R Soc Trop Med Hyg. 2003;97(6):697-701. [ Links ]

11. Mabunda S, Aponte J, Tiago A, Alonso P. A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Malaria Journal. 2009;8(1):74. [ Links ]

12. D'Acremont V, Lengeler C, Mshinda H, Mtasiwa D, Tanner M, Genton B. Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever. PLoS Med. 2009;6(1):e252. [ Links ]

13. Hume J, Barnish G, Mangal T, Armazio L, Streat E, Bates I. Household cost of malaria overdiagnosis in rural Mozambique. Malaria Journal. 2008;7(1):33. [ Links ]

14. Agudelo C, Corredor A, Valero M. Assessing options for an innovative malaria control program on the basis of experience with the new Colombian Health Social Security System. Revista de Salud Pública. 2004;6:1-39. [ Links ]

15. Valero-Bernal M. Persistencia, resurgimiento y resistencia de la malaria en Colombia, periodo 1960-2004. Bogota: Universidad Nacional de Colombia; 2006. [ Links ]

16. Rodríguez MH, Betanzos-Reyes ÁF. Plan de mejoramiento del control de la malaria hacia su eliminación en Mesoamérica. Salud Pública de México. 2011;53:s333-s48. [ Links ]

17. Betanzos Reyes ÁF. La malaria en México. Progresos y desafíos hacia su eliminación. Boletín médico del Hospital Infantil de México. 2011;68:159-68. [ Links ]

18. Prata A., Urdaneta M., McGreevy PB., MS. T. Infrequency of asymptomatic malaria in an endemic area in Amazonas, Brazil. Rev Soc Bras Med Trop. 1988;21(2):51-4. [ Links ]

19. De Andrade AL., Martelli CM., Oliveira RM., Arias JR., Zicker F., Pang L. High prevalence of asymptomatic malaria in gold mining areas in Brazil. Clin Infect Dis. 1995;20(2):475. [ Links ]

20. Osorio L, Todd J, Bradley D. Ausencia de malaria asintomática en escolares de Quibdó, Chocó. Biomédica. 2004;24:13-9. [ Links ]

21. Coura JR, Suárez-Mutis M, Ladeia-Andrade S. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection - a review. Memórias do Instituto Oswaldo Cruz. 2006;101:229-37. [ Links ]

22. Silva-Nunes M, Ferreira M. Clinical spectrum of uncomplicated malaria in semi-immune Amazonians: beyond the " symptomatic " vs " asymptomatic " dichotomy. Memórias do Instituto Oswaldo Cruz. 2007;102:341-8. [ Links ]

23. Cucunubá ZM, Guerra ÁP, Rahirant SJ, Rivera JA, Cortés LJ, Nicholls RS. Asymptomatic Plasmodium spp. infection in Tierralta, Colombia. Memórias do Instituto Oswaldo Cruz. 2008;103:668-73. [ Links ]

24. Instituto Nacional de Salud de Colomba. Vigilancia de la Malaria en Colombia. 2012. En www.ins.gov.co. [ Links ]

25. Valero MV, Amador R, Aponte JJ, Narvaez A, Galindo C, Silva Y, Patarroyo ME., et al. Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia. Vaccine. 1996;14(15):1466-70. [ Links ]

26. Guerra C, Hay S, Lucioparedes L, Gikandi P, Tatem A, Noor A, et al. Assembling a global database of malaria parasite prevalence for the Malaria Atlas Project. Malaria Journal. 2007;6(1):17. [ Links ]

27. González JM, Olano V, Vergara J, Arévalo-Herrera M, Carrasquilla G, Herrera S, et al. Unstable, low-level transmission of malaria on the Colombian Pacific Coast. Ann Trop Med Parasitol. 1997;91:349-58. [ Links ]

28. Panamerican Health Organization, Minister of Health Colombia, Instituto Nacional de Salud. Guía para la atención clínica integral del paciente con malaria. Organización Panamericana de la Salud OPS/ OMS. Convenio de Cooperación Técnica con el Ministerio de la Protección Social Nro 256 de 2009 y Nro 237 de 2010. [Internet]. Consulted: Consulted: http://www.paho.org/COL/2012 . Acceso octubre 4 de 2016. [ Links ]

29. OPS, Ministerio de Salud Colombia, Instituto Nacional de Salud de Colomba. Protocolo para la vigilancia en salud pública de malaria. Bogota, Colombia 2012. [ Links ]

30. CODHES., ACNUR. Crisis Humanitaria en Colombia Persiste. EL PACÍFICO EN DISPUTA. Informe de desplazamiento forzado en 2012. http://www.abcolombia.org.uk/downloads/Informe_Desplazamiento_2012_La_Crisis_Humanitaria_.pdf: CODHES, 2013. [ Links ]

31. Valero-Bernal MV. Proportion of fever atributable to malaria in low endemic areas: London, School f Hygiene and Tropical Medicine; Thesis M.Sc 1996. [ Links ]

32. Bardach A, Ciapponi A, Rey-Ares L, Rojas JI, Mazzoni A, Glujovsky D, et al. Epidemiology of Malaria in Latin America and the Caribbean from 1990 to 2009: Systematic Review and Meta-Analysis. Value in Health Regional Issues. 2015;8:69-79. [ Links ]

33. Schenone H. Parasitology and entomology in the 29th century in Latin American narrative. Bol Chil Parasitol. 2000;55(3-4):66-78. [ Links ]

34. Griffing SM, Villegas L, V. U. Malaria control and elimination, Venezuela, 1800s -1970s. Emerg Infect Dis. 2014;20(10):1697-704. [ Links ]

35. Litsios S. Arnoldo Gabaldón's independent path for malaria control and public health in the tropics: a lost "paradigm" for WHO. Parassitologia. 1998;40(1-2):231-38. [ Links ]

36. Zimmerman RH. Malaria in Sucre State, Venezuela. Cadernos de Saúde Pública. 2000;16:1127-31. [ Links ]

37. Da Silva-Nunes M, Moreno M, Conn JE, Gamboa D, Abeles S, Vinetz JM, et al. Amazonian malaria: Asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Tropica. 2012;121(3):281-91. [ Links ]

38. Kroeger A, Ordoñez-Gonzalez J, Aviña AI. Malaria control reinvented: health sector reform and strategy development in Colombia. Tropical Medicine & International Health. 2002;7 (5): 450-458. [ Links ]

39. Williams HA, Vincent-Mark A, Herrera Y, Chang OJ. A retrospective analysis of the change in anti-malarial treatment policy: Peru A Global Strategy for Malaria Control. Geneva: World Health Organization; 2009. 1-12 p. [ Links ]

40. Alba-Amaya AM., Carreño-Trujillo C, Arce-Cuervo J, Acosta-Wilches L, Valero-Bernal M. Malaria situation in the countries of the Amazon Region. A systematic narrative review of the elimination between 2000-2015. Poster Facultad de Medicina 2015. [ Links ]

41. Gabaldon A. Duration of attack measures in a malaria erradication program. Am J Trop Med Hyg. 1968;17(1):1-12. [ Links ]

42. Flores W, Chang J, Barillas E. Rapid assessment of the performance of malaria control strategies implemented by countries in the Amazon subregion using adequacy criteria: case study World Malaria Report 2010-2011. 1-9 p. [ Links ]

43. Valero-Bernal M. Malaria persistence, resurgence and resistance in Colombia 1960-2004, taking tinto account socio-political, economic and cultural dimensions and their implications for control programmes. Bogota: National University of Colombia; 2006. [ Links ]

44. Najera J, Liese B, Hammer J. Malaria. Disease Control Priorities in Developing Countries. 1993. [ Links ]

45. Barlow R, Grobar L. Cost and benefits of controlling parasitic diseases. 1986. [ Links ]

46. Suárez-Mutis MC, Cuervo P, Leoratti FMS, Moraes-Avila SL, Ferreira AW, Fernandes O, et al. Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil. Revista do Instituto de Medicina Tropical de São Paulo. 2007;49:159-64. [ Links ]

47. Ochoa J, Osorio L. Epidemiología de malaria urbana en Quibdó, Chocó. Biomedica 2006. 2006;26(2):278-85. [ Links ]

48. Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definition for malaria in endemic areas. Statistic in Medicine. 1994;13:2345-58. [ Links ]

49. Armstrong Schellenberg JRM, Smith T, Alonso PL, Hayes RJ. What is clinical malaria. Finding case definition for fields research in Highly endemic areas. Parasitology Today. 1994;10(11):439-42. [ Links ]

Received: February 28, 2016; Revised: August 10, 2015; Accepted: December 08, 2016

Conflict of interest

None.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License